Short Term Trading Week Starting: 23 July, page-49

STTCOMP IPD TA LONG

ImpediMed Limited (IPD) is a medical software technology company that measures, monitors and manages fluid status and tissue composition using bioimpedance spectroscopy (BIS). It is into development, manufacture and sale of BIS devices and software services with a focus on the early detection of lymphoedema and heart failure.

$450m mkt cap and over 2 billion shares on issue, which is a bit ugly. However, recent breakthrough with Payors and relevant insurers practices and codes in the US is going to open the floodgates IMO and immediate target around 35c. Suspect the recent cap raise has just about washed through at 20 to 21.5c.